Compare NRT & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRT | PETS |
|---|---|---|
| Founded | 1975 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Retail-Drug Stores and Proprietary Stores |
| Sector | Energy | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.0M | 69.9M |
| IPO Year | N/A | N/A |
| Metric | NRT | PETS |
|---|---|---|
| Price | $9.19 | $3.04 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.20 |
| AVG Volume (30 Days) | 135.5K | ★ 207.8K |
| Earning Date | 02-27-2026 | 02-02-2026 |
| Dividend Yield | ★ 9.28% | N/A |
| EPS Growth | ★ 56.96 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | $8,734,568.00 | ★ $198,265,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.98 |
| P/E Ratio | $10.11 | ★ N/A |
| Revenue Growth | ★ 49.16 | N/A |
| 52 Week Low | $4.00 | $1.57 |
| 52 Week High | $9.48 | $5.58 |
| Indicator | NRT | PETS |
|---|---|---|
| Relative Strength Index (RSI) | 64.31 | 42.54 |
| Support Level | $8.56 | $3.20 |
| Resistance Level | $9.14 | $3.52 |
| Average True Range (ATR) | 0.58 | 0.12 |
| MACD | -0.04 | -0.06 |
| Stochastic Oscillator | 77.83 | 3.00 |
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.